企庭中国民营经济网
导航菜单

哈药集团哈尔滨道里区房产公开转让

我要供应产权交易AI 精选📍 哈尔滨👁 12026-10-05 07:02
哈药集团制药总厂通过哈尔滨产权交易所公开转让位于哈尔滨市道里区工程小区115栋1层6号的房产,不动产权证号黑(2024)哈尔滨市不动产权第0105938号,项目编号[2026]哈产交ZC038,转让行为已获哈药集团股份有限公司审批并完成评估备案等前置程序。 机会点:这是国企背景的实物资产公开挂牌转让,权属清晰、程序合规,标的为哈尔滨主城区成熟小区底层房产,适合自用或投资。信息披露期为2026年9月29日9时至10月20日10时,竞价于10月20日10时开始,加价幅度1万元或其整数倍,保证金及交易价款通过哈尔滨产权交易所账户结算。 谁该参与:有哈尔滨本地房产购置或投资需求的个人、企业,以及关注国企资产处置机会的机构投资者。 怎么参与:在披露期内向哈尔滨产权交易所提交报名材料并缴纳交易保证金,自行实地踏勘标的、确认现状及瑕疵;仅一个合格受让方时协议成交,两个及以上时网络竞价。竞价结束后5个工作日内签订《房产交易合同》,合同生效后5个工作日内付清全部价款及服务费;网络竞价成交服务费为交易价款的5%,协议成交为1%,不足500元按500元收取。 时间窗口:报名及保证金缴纳截止2026年10月20日10时,逾期无法参与。 事实依据:【企业资产转让公告】哈药集团制药总厂哈尔滨房产转让项目项目信息披露
English version — Harbin Daoli District Property Offered by Harbin Pharmaceutical Group
Harbin Pharmaceutical Group Pharmaceutical General Factory is publicly transferring a property at Unit 6, Floor 1, Building 115, Gongcheng Community, Daoli District, Harbin, through the Harbin Property Rights Exchange. The project number is [2026] Ha Chan Jiao ZC038, and the property ownership certificate is Hei (2024) Harbin Real Estate No. 0105938. The transfer has been approved under the asset transfer procedures of Harbin Pharmaceutical Group Co., Ltd. and has completed all prior approvals, including appraisal filing. The information disclosure period runs from 09:00 on September 29, 2026 to 10:00 on October 20, 2026, with online bidding starting at 10:00 on October 20, 2026. The bid increment is RMB 10,000 or an integer multiple thereof. If only one qualified bidder emerges, the deal is concluded by agreement; if two or more qualify, online bidding determines the transferee. The buyer must sign the Property Transaction Contract within 5 working days after bidding and pay the full price and service fee within 5 working days after the contract takes effect. Service fees are 5% of the transaction price for online bidding and 1% for agreement deals, with a minimum of RMB 500. Payment is settled through the Harbin Property Rights Exchange account. Source: [Corporate Asset Transfer Announcement] Project Information Disclosure for Harbin Property Transfer by Harbin Pharmaceutical Group Pharmaceutical General Factory

相关商机